Fig 1.
Validation of the physiologically based pharmacokinetic strategy against clinical data for an existing rilpivirine sustained-release formulation (600 mg; 100 mg/mL) [6]
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.